IN SPOTLIGHT
Four scenarios on the future of AI in the workplace
AI’s rapid rise in the workplace is opening up new possibilities—some optimistic, others unsettling. We explore how AI could alter job roles, workplace dynamics, and society at large through four different scenarios.
Can We Use Nanobots to Cure Cancer?
Nanobots are small "robots" ranging from 1 to 100 nanometers in size. Scientists are exploring different applications of nanobots in medicine and healthcare, to fight cancer as well as to unblock blood vessels.
Will We Live Longer in the Future?
Human life expectancy is on the rise. Whereas the average person born in 1960 could expect to live to 52.5 years of age, someone born today has an average life expectancy between 79 and 83 years of age. The question many of us ask is: how far can we push the boundaries of our human lifespan?
We Now Have 3D-Printed Human Hearts
A team at the Tel Aviv University in Israel has achieved a major breakthrough by 3D-printing a heart with human tissue and vessels. In the future, this technology could be used to repair damaged hearts or to print entirely new ones, to be used for transplants.
Is Telehealth the Future of Healthcare?
The last time you went to the doctor, how long were you stuck sitting in the waiting room? Unfortunately, for many the answer is usually, “Too long!” You can only read so many 5-year-old magazines before losing patience… However,, thanks to telehealth, this tradition of long wait times might soon come to an end.
When It Comes to Robots in Healthcare, Size Matters
Robotics is changing the future of healthcare. From restoring people's lost abilities to highly precise surgical operations, the potential is enormous. But robots in healthcare can be small too. So small that they can reach almost anywhere inside your body and deliver a highly targeted cure.
Can You Survive with a Pig's Heart?
Scientists have just used the gene-editing CRISPR technology to eliminate a family of viruses in pigs that could be transmitted to humans in transplants or other cases. This new gene-editing technology is here to stay and can profoundly impact genetics as we know it. It may also prove to be a way to eliminate the risks involved with animal-to-human transplants, which could save millions of lives every year.
The Magic Pill
Why are governments investing so much in precision medicine? Why are genomics companies like Illumina or Agilent Technologies, who many of us have never heard of, worth billions more than Snap, Inc or Twitter?